These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

972 related items for PubMed ID: 17118349

  • 1. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M, Rivera-Montoya I, Espinoza A, Romero-Grijalva M, López-Flores R, González J, Terrazas LI.
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [Abstract] [Full Text] [Related]

  • 2. Differential response of antigen presenting cells from susceptible and resistant strains of mice to Taenia crassiceps infection.
    Reyes JL, Terrazas CA, Vera-Arias L, Terrazas LI.
    Infect Genet Evol; 2009 Dec; 9(6):1115-27. PubMed ID: 19465163
    [Abstract] [Full Text] [Related]

  • 3. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR.
    Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
    [Abstract] [Full Text] [Related]

  • 4. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.
    Stamm LM, Räisänen-Sokolowski A, Okano M, Russell ME, David JR, Satoskar AR.
    J Immunol; 1998 Dec 01; 161(11):6180-8. PubMed ID: 9834104
    [Abstract] [Full Text] [Related]

  • 5. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis.
    Terrazas LI, Montero D, Terrazas CA, Reyes JL, Rodríguez-Sosa M.
    Int J Parasitol; 2005 Nov 01; 35(13):1349-58. PubMed ID: 16126211
    [Abstract] [Full Text] [Related]

  • 6. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M.
    J Immunol; 1996 Jan 15; 156(2):644-52. PubMed ID: 8543816
    [Abstract] [Full Text] [Related]

  • 7. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ.
    Immunol Lett; 2006 May 15; 105(1):38-47. PubMed ID: 16466810
    [Abstract] [Full Text] [Related]

  • 8. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 15; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD, Heinzel FP, Shigekane VM, Fisher WL, Locksley RM.
    J Immunol; 1987 Aug 15; 139(4):1303-9. PubMed ID: 3112230
    [Abstract] [Full Text] [Related]

  • 12. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
    Li J, Nolan TJ, Farrell JP.
    Exp Parasitol; 1997 Sep 15; 87(1):47-57. PubMed ID: 9287957
    [Abstract] [Full Text] [Related]

  • 13. SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis.
    Satoskar A, Brombacher F, Dai WJ, McInnes I, Liew FY, Alexander J, Walker W.
    J Immunol; 1997 Nov 15; 159(10):5005-13. PubMed ID: 9366428
    [Abstract] [Full Text] [Related]

  • 14. Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expression in DBA/2 mice infected with Leishmania mexicana.
    Satoskar A, Alexander J.
    Immunology; 1995 Jan 15; 84(1):1-4. PubMed ID: 7890293
    [Abstract] [Full Text] [Related]

  • 15. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
    Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P.
    J Immunol; 1996 Jul 15; 157(2):827-35. PubMed ID: 8752935
    [Abstract] [Full Text] [Related]

  • 16. Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection.
    Vanloubbeeck Y, Jones DE.
    Am J Trop Med Hyg; 2004 Oct 15; 71(4):407-11. PubMed ID: 15516635
    [Abstract] [Full Text] [Related]

  • 17. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
    Shankar AH, Morin P, Titus RG.
    Exp Parasitol; 1996 Nov 15; 84(2):136-43. PubMed ID: 8932763
    [Abstract] [Full Text] [Related]

  • 18. The role of mannose receptor during experimental leishmaniasis.
    Akilov OE, Kasuboski RE, Carter CR, McDowell MA.
    J Leukoc Biol; 2007 May 15; 81(5):1188-96. PubMed ID: 17261547
    [Abstract] [Full Text] [Related]

  • 19. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
    Torrentera FA, Glaichenhaus N, Laman JD, Carlier Y.
    Infect Immun; 2001 Jan 15; 69(1):617-21. PubMed ID: 11119565
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide contributes to host resistance against experimental Taenia crassiceps cysticercosis.
    Alonso-Trujillo J, Rivera-Montoya I, Rodríguez-Sosa M, Terrazas LI.
    Parasitol Res; 2007 May 15; 100(6):1341-50. PubMed ID: 17206501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.